[Impact of a Person Centred Care Model on the quality of life, well-being, and thriving in nursing homes. A cross-sectional study].

Introduction: The aging of the population has led to the introduction of qualitative and quantitative changes in healthcare resources, among which are the introduction of models of person-centred care (PCC), although there is a lack of information on their impact. The objective of this study is to assess the impact of a PCC model on the quality of life, well-being and thriving, in people living in nursing homes METHODS: Cross-sectional study.

Population: all persons who lived indefinitely in the two participating centres that gave their consent.

[Annual economic cost of informal care in Alzheimer's disease].

Introduction: The indirect cost associated with the care of patients with Alzheimer's disease is taken on primarily by the family.

Aim: To describe the cost associated with time dedication, its annual evolution, associated characteristics and related caregiver burden.

Subjects And Methods: Non-institutionalized patients diagnosed with Alzheimer's disease who are managed on an out-patient basis in a diagnosis unit and their primary caregivers.

[Adaptation and convergent validity of a telephone-based Mini-Mental State Examination].

Background And Objective: To adapt to Spanish and to determine the convergent validity of a Telephone Mini-Mental State Examination (t-MMSE) in order to assess the cognitive functions in Alzheimer's disease (AD) patients.

Patients And Method: Prospective and observational study of a clinical sample consisting of patients with dementia from a memory clinic. Consecutive sampling of participants was used and convergent validity of the t-MMSE and MMSE scores was determined using several statistics measures.

[Mortality-associated factors in patients with Alzheimer's disease treated with galantamine].

Background And Objective: To study the effect of clinical and demographic variables on mortality in patients with probable Alzheimer's disease treated with the cholinesterase inhibitor galantamine.

Patients And Method: This retrospective cohort study reviewed 172 medical records, gathering information such as demographic and clinical variables, adverse events, number of withdrawals and duration of treatment with galantamine.

Results: Of 172 patients, 18.

Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.

Background: few studies have analysed the effect of the long-term use of cholinesterase inhibitors (ChEIs) on mortality.

Objective: to compare the long-term effects of galantamine and donepezil treatment on the mortality rate in Alzheimer's disease (AD) patients.

Design: a retrospective cohort study.